| Literature DB >> 29878131 |
Gary Wong1,2,3,4, Anders Leung1,3, Shihua He1, Wenguang Cao1,3, Marc-Antoine De La Vega5, Bryan D Griffin1,3, Geoff Soule1, Gary P Kobinger5, Darwyn Kobasa1,3, Xiangguo Qiu1,3.
Abstract
During 2013-2016, a novel isolate of Ebola virus (EBOV-Makona) caused an epidemic in West Africa. The virus was distinct from known EBOV strains (EBOV-Kikwit and EBOV-Mayinga), which were responsible for previous outbreaks in Central Africa. To investigate the pathogenicity of EBOV-Makona, we engineered and rescued an early isolate (H.sapiens-wt/GIN/2014/Makona-Gueckedou-C07, called rgEBOV-C07) using an updated reverse-genetics system. rgEBOV-C07 was found to be highly pathogenic in both the knockout mouse and ferret models, with median lethal dose values of 0.078 and 0.015 plaque-forming units, respectively. Therefore, these animals are appropriate for screening potential countermeasures against EBOV-Makona without the need for species adaptation.Entities:
Mesh:
Year: 2018 PMID: 29878131 PMCID: PMC6249576 DOI: 10.1093/infdis/jiy141
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226